Company Filing History:
Years Active: 2023-2025
Title: Alfred Theodore Harding: Innovator in Influenza Vaccine Development
Introduction
Alfred Theodore Harding is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of influenza vaccine development, holding a total of 3 patents. His work focuses on creating innovative solutions to combat influenza-related diseases.
Latest Patents
Harding's latest patents include groundbreaking inventions such as "Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same." This invention provides a modified influenza A virus (IAV) that is replication competent and avirulent. It leads to segment exchange when co-infected with a wild type virus, thereby compromising the spread of both viruses. Another significant patent is "Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same." This patent details the development of replication competent engineered influenza viruses that include additional polynucleotides encoding heterologous polypeptides.
Career Highlights
Harding is affiliated with Duke University, where he continues to advance research in the field of virology and vaccine development. His innovative approaches have positioned him as a key figure in the fight against influenza.
Collaborations
He has collaborated with notable colleagues such as Nicholas Scott Heaton and Brook Elizabeth Heaton, contributing to the advancement of research in influenza vaccines.
Conclusion
Alfred Theodore Harding's work exemplifies the importance of innovation in public health, particularly in the development of effective influenza vaccines. His contributions are vital in the ongoing battle against influenza-related diseases.